Iron status (including ferritin, iron, and total iron-binding capacity (TIBC)) in infants undergoing inpatient blood product transfusion

Evaluation of iron status (including ferritin, iron, and total iron-binding capacity (TIBC)) in infants undergoing blood product transfusions

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250921067308N1

Enrollment

Registered

2025-10-04

Start date

2025-10-12

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients are newborns who are hospitalized in the neonatal intensive care unit (NICU) and require multiple transfusions of blood products.. Perinatal hematological disorder, unspecified

Interventions

Intervention 1: Control group: The status of the neonates before receiving blood product transfusion. At this stage, no transfusion intervention is performed, and only a blood sample is taken to measu

Eligibility

Sex/Gender

All

Age

No minimum to 28 Days

Inclusion criteria

Inclusion criteria: Term and preterm newborns 0 to 28 days Needing blood product transfusions

Exclusion criteria

Exclusion criteria: Presence of major congenital anomalies or known disorders of iron metabolism Diagnosis of hemolytic diseases presence of known chromosomal abnormalities or genetic syndromes that affect iron status

Design outcomes

Primary

Measure	Time frame
Iron levels. Timepoint: Before intervention and 24 to 48 hours after the transfusion. Method of measurement: ELISA method.;Ferritin level. Timepoint: Before intervention and 24 to 48 hours after the transfusion. Method of measurement: ELISA method.;Total Iron-Binding Capacity level. Timepoint: Before intervention and 24 to 48 hours after the transfusion. Method of measurement: ELISA method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeily Abbassian

Shahid Beheshti University of Medical Sciences

liaabba2020@gmail.com+98 21 7777 7845

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026